Related Experiment Video

Updated: Mar 19, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.8K

Chewing the fat for Akt1 inhibition and oncosuppression

Sara M Nowinski1, Ashley Solmonson2, Edward M Mills2

  • 1Department of Biochemistry, University of Utah School of Medicine , Salt Lake City, UT, USA.

Molecular & Cellular Oncology
|June 17, 2016
PubMed

Insights

Mitochondrial uncoupling protein 3 (Ucp3) overexpression in skin impedes tumor growth. This occurs through a new pathway inhibiting thymoma viral proto-oncogene 1 (Akt1) by boosting mitochondrial lipid breakdown.

Area of Science:

  • Mitochondrial bioenergetics
  • Cancer biology
  • Dermatology

Background:

  • Mitochondrial uncoupling proteins (UCPs) have catabolic and energy-dissipating functions.
  • These functions appear to contradict the high energy demands characteristic of cancer cells.
  • The role of UCPs in tumorigenesis is not fully understood.

Purpose of the Study:

  • To investigate the role of mitochondrial uncoupling protein 3 (Ucp3) in skin cancer development.
  • To elucidate the novel mechanism by which Ucp3 might impede tumorigenesis.

Main Methods:

  • Overexpression of Ucp3 in the basal epidermis of mice.
  • Analysis of skin tumorigenesis.
  • Investigation of the thymoma viral proto-oncogene 1 (Akt1) signaling pathway.
  • Assessment of mitochondrial lipid catabolism.

Main Results:

  • Overexpression of Ucp3 in the basal epidermis significantly impeded skin tumorigenesis.
  • This protective effect was mediated by a novel pathway involving the inhibition of Akt1.
  • Increased mitochondrial lipid catabolism was identified as the key mechanism driving Akt1 inhibition.

Conclusions:

  • Ucp3 plays a tumor-suppressive role in the skin.
  • Targeting Ucp3 or its downstream pathway may offer a novel therapeutic strategy for skin cancer.
  • Mitochondrial lipid metabolism represents a potential vulnerability in cancer bioenergetics.
Keywords:
AktUCP3keratinocyteslipid catabolismmetabolomicsmitochondriaskin canceruncouplinguncoupling proteins

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K
Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

7.7K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K